Condition
Virus Integration
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Unknown2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05282095Recruiting
Effect of HPV Integration on Prognosis of Young Women With CIN2 in China
NCT05283239Unknown
Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection
NCT05745597Unknown
Prognostic Study of HPV Virus Integration in Women With HSIL
Showing all 3 trials